1. Pseudogene CSPG4P12 inhibits colorectal cancer progression by attenuating epithelial-mesenchymal transition
   Qinqin Song et al, 2024, Brazilian Journal of Medical and Biological Research CrossRef
2. Impact of Chondroitin Sulfate Proteoglycan 4 Pseudogene 12 Genetic Variants on Colorectal Cancer Risk: A Case-Control Study
   Xianlei Zhou et al, 2024, DNA and Cell Biology CrossRef
3. CSPG4P12 polymorphism served as a susceptibility marker for esophageal cancer in Chinese population
   Hongxue Xu et al, 2024, BMC Cancer CrossRef